7/3/26
PT SEMEN INDONESIA (PERSERO) TBK (PSGTF) Thesis: Recent declines in net income and margins have raised concerns about the company's ability to maintain profitability amid rising input costs and competitive pressures.
★ Analysts see FY2027 revenue reaching $35.58T — +3.1% growth in a single year.
What Could Go Wrong 1 Recent price increases in raw materials could pressure margins, with a projected 5% decline in gross margin over the next two quarters. 2 Emerging competition from alternative building materials could capture 10% of the market share in the next two years. 3 Regulatory changes impacting environmental standards and production processes 4 Technological disruption in cement production methods 5 Increased competition from domestic and international cement producers 6 Potential market entry by new players with lower-cost production capabilities 7 Low net margins could limit financial flexibility and growth investments 8 Potential liquidity risks if cash flows decline further 0.1 0.1 0.1 0.1 0.2 0.07 PSGTF Daily 0.07 Feb '26 Mar '26 May '26 Jul '26
My Notes "Management noted, 'We are facing significant challenges in maintaining our margins due to fluctuating raw material prices.'" Moat: The company's established market position and brand loyalty provide a moderate level of competitive advantage. Watch: The rise of alternative construction materials poses a significant long-term threat to traditional cement producers. value - Investors may be drawn to the stock due to its low valuation metrics despite current operational challenges. Higher interest rates can increase financing costs for construction projects, potentially dampening demand for cement and impacting revenue. Watch on earnings: Domestic cement demand growth rate, Average selling price of cement, Operating cash flow trends. One Sentence Summary: The bear case: recent price increases in raw materials could pressure margins, with a projected 5% decline in gross margin over the next two quarters.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.